Onkar M. P. Singh

Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.

Peter Ertl, James M. Woolven, P. Ertl, 2002, Journal of medicinal chemistry.

Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.

David Haigh, Malcolm Ellis, George Burton, 2007, Journal of medicinal chemistry.